COF
67
2
ORCL
28
3
LB
22
-7
ADP
62
-3
O
35
-7
TRV
48
-10
XRAY
28
-3
PHM
55
-3
UAL
82
3
COP
40
-2
EQR
39
-3
PRU
77
-2
LLY
68
-2
ETN
61
-3
HP
34
-7
IFF
53
2
KIM
51
-3
ETR
52
-3
PLD
40
-8
ALLE
41
-9
COF
67
2
ORCL
28
3
LB
22
-7
ADP
62
-3
O
35
-7
TRV
48
-10
XRAY
28
-3
PHM
55
-3
UAL
82
3
COP
40
-2
EQR
39
-3
PRU
77
-2
LLY
68
-2
ETN
61
-3
HP
34
-7
IFF
53
2
KIM
51
-3
ETR
52
-3
PLD
40
-8
ALLE
41
-9
Financhill
Back

ProShares UltraShort Consumer Discretionary Vs. Nektar Therapeutics Industry Stock Comparison

Sell
19

SCC
ProShares UltraShort Consumer Discretionary

Last Price:
$14.15
Seasonality Move:
-3.14%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.63
Seasonality Move:
11.58%
Sell
19
ProShares UltraShort Consumer Discretionary (SCC) is a Sell

Is ProShares UltraShort Consumer Discretionary a Buy, Sell or Hold?

  • The current ProShares UltraShort Consumer Discretionary [SCC] share price is $13.93. The Score for SCC is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • SCC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SCC Stock Price Chart

What is ProShares UltraShort Consumer Discretionary's stock price today?

  • The ProShares UltraShort Consumer Discretionary share price today is $13.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SCC is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

SCC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 36.97 Sell
Chaikin Money Flow: -5169 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

SCC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.38 Sell
20-day SMA: 15.02 Sell
50-day SMA: 14.92 Sell
200-day SMA: 17.9 Sell
8-day EMA: 14.32 Sell
20-day EMA: 14.67 Sell
50-day EMA: 14.95 Sell
200-day EMA: 17.34 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

ProShares UltraShort Consumer Discretionary Earnings Growth & SCC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

ProShares UltraShort Consumer Discretionary Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):